TO RECEIVE AND CONSIDER THE COMPANYS FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024
TO APPROVE THE DIRECTORS REMUNERATION REPORT
TO RE-ELECT CHERYL MACDIARMID AS A DIRECTOR OF THE COMPANY
TO RE-ELECT JORDAN CLARK AS A DIRECTOR OF THE COMPANY
TO RE-ELECT NICK ROBERTS AS A DIRECTOR OF THE COMPANY
TO RE-APPOINT ERNST AND YOUNG AS AUDITORS OF THE COMPANY
TO AUTHORISE THE DIRECTORS TO DETERMINE THE REMUNERATION OF THE AUDITORS
TO AUTHORISE THE DIRECTORS TO ALLOT ORDINARY SHARES
TO AUTHORISE THE DIRECTORS TO DIS-APPLY STATUTORY PRE-EMPTION RIGHTS PURSUANT TO SECTION 570 OF THE COMPANIES ACT 2006
TO AUTHORISE THE COMPANY TO MAKE MARKET PURCHASES OF ITS ORDINARY SHARES
TO APPROVE THE DIACEUTICS UNAPPROVED SHARE OPTION PLAN